FKBPL and preeclampsia: We demonstrated that FKBPL expression analyzed against its target, CD44, as a CD44/FKBPL ratio, could be used as a potential predictive and diagnostic tool for preeclampsia, although its role in the pathogenesis of preeclampsia requires further elucidation.